Poliner L R, Buja L M, Parkey R W, Bonte F J, Willerson J T
Circulation. 1979 Feb;59(2):257-67. doi: 10.1161/01.cir.59.2.257.
Scintigraphic, clinical and pathological findings were correlated in 52 patients studied by technetium-99m stannous pyrophosphate (99mTc-PYP) myocardial scintigraphy before death or surgical resection of myocardium. Fifty-nine clinical events were studied with scintigraphy in the 52 patients; 41 of the 59 were associated with one or more abnormal 99mTc-PYP studies and 18 with normal 99mTc-PYP scintigrams. Myocardial scintigrams were positive in 29 of 31 cases with clinicopathological evidence of a corresponding discrete, grossly obvious acute myocardial infarct, including 16 of 16 transmural myocardial infarcts and 13 of 15 subendocardial infarcts. In 16 of 18 cases, negative myocardial scintigrams correlated with the absence of acute myocardial infarction determined by clinicopathological evidence. In two cases small subendocardial infarcts (less than 3 g) were not detected by 99mTc-PYP myocardial scintigraphy. Of the 12 additional instances of positive 99mTc-PYP myocardial scintigrams, five were associated with clinical unstable angina pectoris and seven were in the category of persistently positive scintigrams, since the scans were obtained 2.5 months or longer after proven or suspected acute myocardial infarcts. In all 12 instances, the positive 99mTc-PYP scintigrams were associated with evidence of multifocal irreversible myocardial damage consisting of myocytolysis, coagulation necrosis and/or fibrosis, and the histological age of the lesions was compatible with acute injury corresponding to the time of scintigraphy. The findings indicate that a positive 99mTc-PYP myocardial scintigram is a sensitive indicator of significant myocardial injury which may occur as confluent coagulation necrosis corresponding to clinical acute myocardial infarction, or as multifocal coagulation necrosis or myocytolysis associated with unstable angina pectoris or recurrent ischemic heart disease, especially after previous infarctions.
对52例患者在死亡或心肌手术切除前进行了锝-99m焦磷酸亚锡(99mTc-PYP)心肌闪烁显像,并将闪烁显像、临床及病理结果进行了对比。52例患者共进行了59次临床事件的闪烁显像检查;59次检查中的41次与一项或多项99mTc-PYP异常检查相关,18次与99mTc-PYP闪烁显像正常相关。31例经临床病理证实有相应离散、肉眼明显的急性心肌梗死的病例中,29例心肌闪烁显像呈阳性,包括16例透壁性心肌梗死中的16例以及15例心内膜下梗死中的13例。18例中有16例心肌闪烁显像阴性与临床病理证据显示无急性心肌梗死相关。有2例心内膜下小梗死(小于3g)未被99mTc-PYP心肌闪烁显像检测到。另外12例99mTc-PYP心肌闪烁显像阳性的病例中,5例与临床不稳定型心绞痛相关,7例属于闪烁显像持续阳性,因为这些扫描是在已证实或怀疑的急性心肌梗死后2.5个月或更长时间进行的。在所有12例中,99mTc-PYP闪烁显像阳性与多灶性不可逆心肌损伤的证据相关,包括肌细胞溶解、凝固性坏死和/或纤维化,病变的组织学年龄与闪烁显像时的急性损伤相符。这些发现表明,99mTc-PYP心肌闪烁显像阳性是显著心肌损伤的敏感指标,这种损伤可能表现为与临床急性心肌梗死相对应的融合性凝固性坏死,或表现为与不稳定型心绞痛或复发性缺血性心脏病相关的多灶性凝固性坏死或肌细胞溶解,尤其是在既往梗死之后。